• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus ( 2019;43:582-9).

作者信息

Sohn Tae Seo

机构信息

Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

出版信息

Diabetes Metab J. 2019 Dec;43(6):909-910. doi: 10.4093/dmj.2019.0205.

DOI:10.4093/dmj.2019.0205
PMID:31902148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6943272/
Abstract
摘要

相似文献

1
Letter: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus ( 2019;43:582-9).信函：瑞舒伐他汀单药治疗20毫克与瑞舒伐他汀5毫克和依折麦布10毫克联合治疗对2型糖尿病患者血脂参数的疗效比较（2019年；43卷：582 - 589页）
Diabetes Metab J. 2019 Dec;43(6):909-910. doi: 10.4093/dmj.2019.0205.
2
Response: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus ( 2019;43:582-9).回应：瑞舒伐他汀单药20毫克与瑞舒伐他汀5毫克和依折麦布10毫克联合治疗对2型糖尿病患者血脂参数的疗效比较（2019年；43:582 - 589）
Diabetes Metab J. 2019 Dec;43(6):915-916. doi: 10.4093/dmj.2019.0213.
3
Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus.瑞舒伐他汀单药20mg与瑞舒伐他汀5mg及依折麦布10mg联合治疗对2型糖尿病患者血脂参数的疗效比较
Diabetes Metab J. 2019 Oct;43(5):582-589. doi: 10.4093/dmj.2018.0124. Epub 2019 Jan 16.
4
Comparative Efficacy of Rosuvastatin Monotherapy and Rosuvastatin/Ezetimibe Combination Therapy on Insulin Sensitivity and Vascular Inflammatory Response in Patients with Type 2 Diabetes Mellitus.瑞舒伐他汀单药治疗与瑞舒伐他汀/依折麦布联合治疗对 2 型糖尿病患者胰岛素敏感性和血管炎症反应的比较疗效。
Diabetes Metab J. 2024 Jan;48(1):112-121. doi: 10.4093/dmj.2022.0402. Epub 2024 Jan 3.
5
The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study.在 2 型糖尿病合并高心血管疾病风险的患者中，中等强度瑞舒伐他汀联合依折麦布与高强度瑞舒伐他汀的疗效和安全性：一项随机、多中心、开放、平行、四期研究。
Diabetes Metab J. 2023 Nov;47(6):818-825. doi: 10.4093/dmj.2023.0171. Epub 2023 Nov 24.
6
A Comparison of Rosuvastatin Monotherapy and Rosuvastatin Plus Ezetimibe Combination Therapy in Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.瑞舒伐他汀单药治疗与瑞舒伐他汀联合依折麦布治疗2型糖尿病患者的比较：一项随机对照试验的荟萃分析
Cureus. 2024 Jun 2;16(6):e61526. doi: 10.7759/cureus.61526. eCollection 2024 Jun.
7
Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study.瑞舒伐他汀/依折麦布联合治疗与瑞舒伐他汀单药治疗对2型糖尿病患者脂蛋白的疗效及安全性比较：多中心随机对照研究
Diabetes Ther. 2020 Apr;11(4):859-871. doi: 10.1007/s13300-020-00778-1. Epub 2020 Feb 17.
8
Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes.依折麦布 10 毫克联合瑞舒伐他汀 2.5 毫克与瑞舒伐他汀 5 毫克单药治疗 2 型糖尿病患者高胆固醇血症的疗效。
Lipids Health Dis. 2013 Sep 22;12:137. doi: 10.1186/1476-511X-12-137.
9
Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia.依折麦布与瑞舒伐他汀联合治疗与瑞舒伐他汀单药治疗原发性高胆固醇血症患者的疗效和安全性。
Clin Ther. 2018 Jun;40(6):993-1013. doi: 10.1016/j.clinthera.2018.04.015. Epub 2018 May 30.
10
A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial.一项 III 期、多中心、随机、双盲、阳性对照临床试验，旨在比较依折麦布和瑞舒伐他汀联合治疗与瑞舒伐他汀单药治疗在高胆固醇血症患者中的疗效和安全性：I-ROSETTE（Ildong 瑞舒伐他汀和依折麦布治疗高胆固醇血症）随机对照试验。
Clin Ther. 2018 Feb;40(2):226-241.e4. doi: 10.1016/j.clinthera.2017.12.018.

本文引用的文献

1
2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea.2019 年韩国 2 型糖尿病临床实践指南。
Diabetes Metab J. 2019 Aug;43(4):398-406. doi: 10.4093/dmj.2019.0137.
2
Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status.韩国糖尿病概况手册 2018：现状评估。
Diabetes Metab J. 2019 Aug;43(4):487-494. doi: 10.4093/dmj.2019.0067. Epub 2019 Jul 17.
3
Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus.瑞舒伐他汀单药20mg与瑞舒伐他汀5mg及依折麦布10mg联合治疗对2型糖尿病患者血脂参数的疗效比较
Diabetes Metab J. 2019 Oct;43(5):582-589. doi: 10.4093/dmj.2018.0124. Epub 2019 Jan 16.
4
Diabetes and Subclinical Coronary Atherosclerosis.糖尿病与亚临床冠状动脉粥样硬化
Diabetes Metab J. 2018 Oct;42(5):355-363. doi: 10.4093/dmj.2018.0041.
5
Diabetes Fact Sheet in Korea, 2016: An Appraisal of Current Status.《2016年韩国糖尿病情况说明书：现状评估》
Diabetes Metab J. 2018 Oct;42(5):415-424. doi: 10.4093/dmj.2018.0017. Epub 2018 Aug 9.
6
Ten-Year Mortality Trends for Adults with and without Diabetes Mellitus in South Korea, 2003 to 2013.2003年至2013年韩国糖尿病患者与非糖尿病患者的十年死亡率趋势
Diabetes Metab J. 2018 Oct;42(5):394-401. doi: 10.4093/dmj.2017.0088. Epub 2018 Apr 26.
7
Past and Current Status of Adult Type 2 Diabetes Mellitus Management in Korea: A National Health Insurance Service Database Analysis.韩国成人2型糖尿病管理的过去与现状：一项国民健康保险服务数据库分析
Diabetes Metab J. 2018 Apr;42(2):93-100. doi: 10.4093/dmj.2018.42.2.93.
8
Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus.中等强度他汀类药物治疗韩国2型糖尿病患者血脂异常的疗效
Diabetes Metab J. 2017 Feb;41(1):23-30. doi: 10.4093/dmj.2017.41.1.23. Epub 2016 Dec 16.
9
Racial Differences in the Cholesterol-Lowering Effect of Statin.他汀类药物降胆固醇作用的种族差异。
J Atheroscler Thromb. 2017 Jan 1;24(1):19-25. doi: 10.5551/jat.RV16004. Epub 2016 Oct 12.
10
Demystifying the management of hypertriglyceridaemia.揭开高甘油三酯血症管理的神秘面纱。
Nat Rev Cardiol. 2013 Nov;10(11):648-61. doi: 10.1038/nrcardio.2013.140. Epub 2013 Sep 24.